| Product Code: ETC6749927 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Despite a decrease in the growth rate from 2023 to 2024, China import market for pancrelipase remained concentrated with high HHI levels in 2024. Top exporting countries like Puerto Rico, Metropolitan France, Germany, Spain, and Italy continued to contribute significantly to China supply chain. The negative CAGR from 2020 to 2024 indicates a decline in demand or market dynamics for pancrelipase imports in China. It will be crucial for market players to closely monitor these trends and adapt their strategies to navigate the changing landscape of the Chinese market for pancrelipase.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Pancrelipase Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Pancrelipase Market Revenues & Volume, 2021 & 2031F |
3.3 China Pancrelipase Market - Industry Life Cycle |
3.4 China Pancrelipase Market - Porter's Five Forces |
3.5 China Pancrelipase Market Revenues & Volume Share, By Age, 2021 & 2031F |
3.6 China Pancrelipase Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 China Pancrelipase Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Pancrelipase Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of pancreatic disorders and diseases in China |
4.2.2 Growing awareness about pancreatic enzyme replacement therapy (PERT) in the country |
4.2.3 Rising healthcare expenditure and improving healthcare infrastructure in China |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the approval of pancrelipase products in China |
4.3.2 Limited availability of skilled healthcare professionals for prescribing pancrelipase medications |
5 China Pancrelipase Market Trends |
6 China Pancrelipase Market, By Types |
6.1 China Pancrelipase Market, By Age |
6.1.1 Overview and Analysis |
6.1.2 China Pancrelipase Market Revenues & Volume, By Age, 2021- 2031F |
6.1.3 China Pancrelipase Market Revenues & Volume, By Children, 2021- 2031F |
6.1.4 China Pancrelipase Market Revenues & Volume, By Adults and Geriatrics, 2021- 2031F |
6.2 China Pancrelipase Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 China Pancrelipase Market Revenues & Volume, By Chronic Pancreatitis, 2021- 2031F |
6.2.3 China Pancrelipase Market Revenues & Volume, By Cystic Fibrosis, 2021- 2031F |
6.2.4 China Pancrelipase Market Revenues & Volume, By Others, 2021- 2031F |
6.3 China Pancrelipase Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 China Pancrelipase Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.3.3 China Pancrelipase Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.4 China Pancrelipase Market Revenues & Volume, By Drug Store and Retail Pharmacies, 2021- 2031F |
7 China Pancrelipase Market Import-Export Trade Statistics |
7.1 China Pancrelipase Market Export to Major Countries |
7.2 China Pancrelipase Market Imports from Major Countries |
8 China Pancrelipase Market Key Performance Indicators |
8.1 Patient adherence rate to prescribed pancrelipase treatment regimen |
8.2 Number of healthcare facilities offering PERT in China |
8.3 Research and development investment in pancrelipase formulations and delivery methods |
9 China Pancrelipase Market - Opportunity Assessment |
9.1 China Pancrelipase Market Opportunity Assessment, By Age, 2021 & 2031F |
9.2 China Pancrelipase Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 China Pancrelipase Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Pancrelipase Market - Competitive Landscape |
10.1 China Pancrelipase Market Revenue Share, By Companies, 2024 |
10.2 China Pancrelipase Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |